Cellares Appoints Ossama Eissa as COO to Scale Global Cell Therapy Manufacturing
Key Highlights Ossama Eissa joins Cellares as COO to expand global cell therapy manufacturing. Eissa brings over 20 years of…
Browsing Tag
Fabian Gerlinghaus
5 posts
Kite to Evaluate Cellares’ Automated Cell Shuttle Platform
Key Highlights Kite evaluates Cellares’ automated Cell Shuttle platform. Proof-of-concept evaluation to assess future manufacturing viability. Potential to…
Bristol Myers Squibb Partners with Cellares in $380M CAR T Cell Therapy Deal
Key Highlights Worldwide agreement worth up to $380M includes capacity reservation and supply for CAR T cell therapies. Cellares…
Cellares Unveils Automated QC Solution, Cell Q™
Key Highlights Cell Q™ automates quality control, drastically increasing throughput with capacity for up to 6,000 batches/year. Designed…
Cellares Secures $255M Series C Funding to Revolutionize Cell Therapy Manufacturing
Cellares, a pioneering force in cell therapy manufacturing, has announced a successful $255 million Series C funding round.…